D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
CALL
Chemours
CC
$2.53B
| $702K | ﹤0.01% |
18,900
-69,400
| -79% | -$2.53M |
|
2777
First Financial Corp
THFF
$923M
| $702K | ﹤0.01% |
+16,722
| New | +$709K |
|
2778
Visteon
VC
$2.79B
| $702K | ﹤0.01% |
10,416
-28,459
| -73% | -$2.14M |
|
2779
Xerox
XRX
$358M
| $701K | ﹤0.01% |
21,912
-1,286,379
| -98% | -$36.3M |
|
2780
eGain
EGAN
$186M
| $696K | ﹤0.01% |
66,589
-7,693
| -10% | -$72.9K |
|
|
ETFC
2781
CALL
DELISTED
E*Trade Financial Corporation
ETFC
| $696K | ﹤0.01% |
15,000
-100
| -0.7% | -$4.76K |
|
2782
Graham Corp
GHM
$1.19B
| $695K | ﹤0.01% |
35,413
+136
| +0.4% | +$3.01K |
|
2783
Freeport-McMoran
FCX
$88.3B
| $694K | ﹤0.01% |
53,849
-2,724,756
| -98% | -$33M |
|
|
HAYN
2784
DELISTED
Haynes International, Inc.
HAYN
| $694K | ﹤0.01% |
21,148
-21,584
| -51% | -$697K |
|
2785
PUT
Brighthouse Financial
BHF
$3.64B
| $693K | ﹤0.01% |
19,100
-35,400
| -65% | -$1.33M |
|
2786
Camtek
CAMT
$6.89B
| $693K | ﹤0.01% |
77,645
+55,323
| +248% | +$448K |
|
2787
Tredegar Corp
TG
$255M
| $692K | ﹤0.01% |
+42,882
| New | +$726K |
|
2788
RPC Inc
RES
$1.21B
| $690K | ﹤0.01% |
+60,454
| New | +$646K |
|
2789
Frontline
FRO
$8.59B
| $689K | ﹤0.01% |
106,586
+92,711
| +668% | +$551K |
|
|
ABMD
2790
DELISTED
Abiomed Inc
ABMD
| $687K | ﹤0.01% |
2,405
-6,587
| -73% | -$2.19M |
|
2791
PUT
PetMed Express
PETS
$41.9M
| $683K | ﹤0.01% |
30,000
+5,000
| +20% | +$113K |
|
2792
CALL
Rapid7
RPD
$651M
| $683K | ﹤0.01% |
+13,500
| New | +$578K |
|
|
LXFT
2793
DELISTED
Luxoft Holding, Inc.
LXFT
| $683K | ﹤0.01% |
11,641
-27,244
| -70% | -$1.55M |
|
2794
CubeSmart
CUBE
$9.57B
| $682K | ﹤0.01% |
21,292
-385,022
| -95% | -$11.7M |
|
2795
PUT
Asbury Automotive
ABG
$4.22B
| $680K | ﹤0.01% |
9,800
| – | – |
|
2796
CALL
Deutsche Bank
DB
$67.5B
| $680K | ﹤0.01% |
83,800
-65,200
| -44% | -$571K |
|
2797
Scholastic
SCHL
$749M
| $680K | ﹤0.01% |
17,108
+7,126
| +71% | +$294K |
|
|
WDR
2798
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $679K | ﹤0.01% |
+39,269
| New | +$692K |
|
2799
Sonos
SONO
$1.86B
| $678K | ﹤0.01% |
+65,921
| New | +$715K |
|
|
SOHU
2800
Sohu.com
SOHU
$345M
| $677K | ﹤0.01% |
40,826
-16,877
| -29% | -$326K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.